FINANCIALS

HALO Halozyme Therapeutics Inc 1159036

Income Statement
Revenue	halo-20241231	1,015,324,000
Net Income	halo-20241231	444,091,000
Profit Margin		43.74%

Balance Sheet
Current Assets	1,085,340,000
Assets	2,063,477,000
Current Liabilities	139,100,000
Liabilities	1,699,656,000
Equity	363,821,000
Shares Out	118,474,000

Cash Flow Statement
Operating Cash Flow	479,064,000
Investing Cash Flow	-262,723,000

Market Analysis
Market Cap	8,103,642,300
Price	68.40
BVPS	15.94
PB	4.00
EPS	2.56
PE	26.74
PS	8.32
FCF	216,341,000

Dividends

Earnings

Find a discrepancy? The most accurate way to find company fundamental data is to view HALO documents filed with the SEC.

HALO Filings Clear

View A List of Tickers